Interestingly, both hMSC-Ex-4 and wild-type hMSC treated with soluble Ex-4 exhibited elevated mRNA expression of GLP-1-R in a dose-dependent manner, suggesting a feedback mechanism that may potentiate hMSC responsiveness to Ex-4 [18]
In May 2026, Eli Lilly announced it will present highly anticipated data on Foundayo, Mounjaro, and retatrutide at the American Diabetes Associations (ADA) 86th Scientific Sessions
Hurtado-Carneiro V, Sanz C, Roncero I, Vazquez P, Blazquez E, Alvarez E
The feedback form on this page can be used to report content that is not accurate, up-to-date or questionable in any manner
Epithalon is explored for its influence on chromosomal end protection mechanisms, contributing to investigation of cellular stability pathways